Entry
Name
Amyotrophic lateral sclerosis - Homo sapiens (human)
Description
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by a progressive degeneration of motor neurons in the brain and spinal cord. In 90% of patients, ALS is sporadic, with no clear genetic linkage. On the other hand, the remaining 10% of cases show familial inheritance, with mutations in SOD1, TDP43(TARDBP), FUS, or C9orf72 genes being the most frequent causes. In spite of such difference, familial ALS and sporadic ALS have similarities in their pathological features. Proposed disease mechanisms contributing to motor neuron degeneration in ALS are: impaired proteostasis, aberrant RNA processing, mitochondrial disfunction and oxidative stress, microglia activation, and axonal dysfunction.
Class
Human Diseases; Neurodegenerative disease
BRITE hierarchy
Pathway map
Ortholog table
Network
Element
N01135 Mutation-caused aberrant SOD1 to intrinsic apoptotic pathway
N01136 Mutation-caused aberrant TDP43 to electron transfer in Complex I
N01138 Mutation-inactivated OPTN to PINK-Parkin-mediated autophagosome formation
N01139 Mutation-inactivated p62 to PINK-Parkin-mediated autophagosome formation
N01141 Mutation-inactivated TBK1 to TBK1-mediated autophagosome formation
N01143 Mutation-inactivated C9orf72 to C9orf72-mediated autophagy initiation
N01144 Mutation-caused aberrant SOD1 to 26S proteasome-mediated protein degradation
N01145 Mutation-inactivated VCP to 26S proteasome-mediated protein degradation
N01146 Mutation-inactivated UBQLN2 to 26S proteasome-mediated protein degradation
N01147 Mutation-caused aberrant SOD1 to ATF6-mediated transcription
N01148 Mutation-caused aberrant SOD1 to IRE1a-XBP1 signaling pathway
N01149 Mutation-caused aberrant SOD1 to PERK-ATF4 signaling pathway
N01150 Mutation-inactivated VAPB to ATF6-mediated transcription
N01151 Mutation-inactivated SIGMAR1 to Ca2+ -apoptotic pathway
N01153 Mutation-caused aberrant GLE1 to nuclear export of mRNA
N01155 Mutation-caused aberrant TDP43 to TDP-43-regulated splicing
N01157 Mutation-caused aberrant FUS to FUS-regulated splicing
N01158 Mutation-caused aberrant DCTN1 to retrograde axonal transport
N01159 Mutation-caused aberrant TUBA4A to retrograde axonal transport
N01160 Mutation-caused aberrant SOD1 to retrograde axonal transport
N01162 Mutation-caused aberrant PFN1 to actin polymerization
N01164 Mutation-inactivated ERBB4 to NRG-ERBB4-PI3K signaling pathway
Disease
H00058 Amyotrophic lateral sclerosis (ALS)
Drug
D11811 Tofersen (JAN/USAN/INN)
Organism
Homo sapiens (human) [GN:
hsa ]
Gene
637 BID; BH3 interacting domain death agonist [KO:K04726 ]
596 BCL2; BCL2 apoptosis regulator [KO:K02161 ]
581 BAX; BCL2 associated X, apoptosis regulator [KO:K02159 ]
572 BAD; BCL2 associated agonist of cell death [KO:K02158 ]
317 APAF1; apoptotic peptidase activating factor 1 [KO:K02084 ]
4731 NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944 ]
4694 NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945 ]
4695 NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946 ]
4696 NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947 ]
4697 NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948 ]
56901 NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948 ]
4698 NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949 ]
4700 NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950 ]
4701 NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951 ]
4702 NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952 ]
4704 NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953 ]
4705 NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954 ]
4706 NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955 ]
126328 NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956 ]
55967 NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352 ]
51079 NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353 ]
4707 NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957 ]
4708 NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958 ]
4709 NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959 ]
4710 NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960 ]
4711 NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961 ]
4712 NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962 ]
4713 NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963 ]
4714 NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964 ]
4715 NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965 ]
4716 NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966 ]
54539 NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351 ]
4724 NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937 ]
4725 NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938 ]
4726 NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939 ]
4717 NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967 ]
4718 NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968 ]
6389 SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234 ] [EC:1.3.5.1 ]
6390 SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235 ] [EC:1.3.5.1 ]
6391 SDHC; succinate dehydrogenase complex subunit C [KO:K00236 ]
6392 SDHD; succinate dehydrogenase complex subunit D [KO:K00237 ]
7386 UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411 ] [EC:7.1.1.8 ]
7384 UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414 ]
7385 UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415 ]
7388 UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416 ]
440567 UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416 ]
7381 UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417 ]
27089 UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418 ]
29796 UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419 ]
10975 UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420 ]
4514 COX3; cytochrome c oxidase subunit III [KO:K02262 ]
4513 COX2; cytochrome c oxidase subunit II [KO:K02261 ]
84701 COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263 ]
1327 COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263 ]
9377 COX5A; cytochrome c oxidase subunit 5A [KO:K02264 ]
1329 COX5B; cytochrome c oxidase subunit 5B [KO:K02265 ]
1337 COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266 ]
1339 COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266 ]
1340 COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267 ]
1345 COX6C; cytochrome c oxidase subunit 6C [KO:K02268 ]
1346 COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270 ]
1347 COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270 ]
9167 COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270 ]
1349 COX7B; cytochrome c oxidase subunit 7B [KO:K02271 ]
1350 COX7C; cytochrome c oxidase subunit 7C [KO:K02272 ]
1351 COX8A; cytochrome c oxidase subunit 8A [KO:K02273 ]
498 ATP5F1A; ATP synthase F1 subunit alpha [KO:K02132 ]
509 ATP5F1C; ATP synthase F1 subunit gamma [KO:K02136 ]
513 ATP5F1D; ATP synthase F1 subunit delta [KO:K02134 ]
514 ATP5F1E; ATP synthase F1 subunit epsilon [KO:K02135 ]
515 ATP5PB; ATP synthase peripheral stalk-membrane subunit b [KO:K02127 ]
516 ATP5MC1; ATP synthase membrane subunit c locus 1 [KO:K02128 ]
517 ATP5MC2; ATP synthase membrane subunit c locus 2 [KO:K02128 ]
518 ATP5MC3; ATP synthase membrane subunit c locus 3 [KO:K02128 ]
10476 ATP5PD; ATP synthase peripheral stalk subunit d [KO:K02138 ]
539 ATP5PO; ATP synthase peripheral stalk subunit OSCP [KO:K02137 ]
522 ATP5PF; ATP synthase peripheral stalk subunit F6 [KO:K02131 ]
7416 VDAC1; voltage dependent anion channel 1 [KO:K05862 ]
10452 TOMM40; translocase of outer mitochondrial membrane 40 [KO:K11518 ]
84134 TOMM40L; translocase of outer mitochondrial membrane 40 like [KO:K11518 ]
440738 MAP1LC3C; microtubule associated protein 1 light chain 3 gamma [KO:K10435 ]
81631 MAP1LC3B; microtubule associated protein 1 light chain 3 beta [KO:K10435 ]
84557 MAP1LC3A; microtubule associated protein 1 light chain 3 alpha [KO:K10435 ]
643246 MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2 [KO:K10435 ]
392288 MAP1LC3BP1; microtubule associated protein 1 light chain 3 beta pseudogene 1 [KO:K10435 ]
10010 TANK; TRAF family member associated NFKB activator [KO:K12650 ]
4218 RAB8A; RAB8A, member RAS oncogene family [KO:K07901 ]
116442 RAB39B; RAB39B, member RAS oncogene family [KO:K07925 ]
5861 RAB1A; RAB1A, member RAS oncogene family [KO:K07874 ]
9821 RB1CC1; RB1 inducible coiled-coil 1 [KO:K17589 ]
55626 AMBRA1; autophagy and beclin 1 regulator 1 [KO:K17985 ]
29982 NRBF2; nuclear receptor binding factor 2 [KO:K21246 ]
26100 WIPI2; WD repeat domain, phosphoinositide interacting 2 [KO:K17908 ]
55062 WIPI1; WD repeat domain, phosphoinositide interacting 1 [KO:K17908 ]
57679 ALS2; alsin Rho guanine nucleotide exchange factor ALS2 [KO:K04575 ]
5868 RAB5A; RAB5A, member RAS oncogene family [KO:K07887 ]
25978 CHMP2B; charged multivesicular body protein 2B [KO:K12192 ]
9896 FIG4; FIG4 phosphoinositide 5-phosphatase [KO:K22913 ] [EC:3.1.3.-]
80208 SPG11; SPG11 vesicle trafficking associated, spatacsin [KO:K19026 ]
5534 PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268 ]
5535 PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268 ]
5701 PSMC2; proteasome 26S subunit, ATPase 2 [KO:K03061 ]
5700 PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062 ]
5704 PSMC4; proteasome 26S subunit, ATPase 4 [KO:K03063 ]
5706 PSMC6; proteasome 26S subunit, ATPase 6 [KO:K03064 ]
5702 PSMC3; proteasome 26S subunit, ATPase 3 [KO:K03065 ]
5705 PSMC5; proteasome 26S subunit, ATPase 5 [KO:K03066 ]
5708 PSMD2; proteasome 26S subunit ubiquitin receptor, non-ATPase 2 [KO:K03028 ]
5707 PSMD1; proteasome 26S subunit, non-ATPase 1 [KO:K03032 ]
5709 PSMD3; proteasome 26S subunit, non-ATPase 3 [KO:K03033 ]
5715 PSMD9; proteasome 26S subunit, non-ATPase 9 [KO:K06693 ]
5718 PSMD12; proteasome 26S subunit, non-ATPase 12 [KO:K03035 ]
5717 PSMD11; proteasome 26S subunit, non-ATPase 11 [KO:K03036 ]
9861 PSMD6; proteasome 26S subunit, non-ATPase 6 [KO:K03037 ]
5713 PSMD7; proteasome 26S subunit, non-ATPase 7 [KO:K03038 ]
5719 PSMD13; proteasome 26S subunit, non-ATPase 13 [KO:K03039 ]
5710 PSMD4; proteasome 26S subunit ubiquitin receptor, non-ATPase 4 [KO:K03029 ]
10213 PSMD14; proteasome 26S subunit, non-ATPase 14 [KO:K03030 ]
5714 PSMD8; proteasome 26S subunit, non-ATPase 8 [KO:K03031 ]
11047 ADRM1; ADRM1 26S proteasome ubiquitin receptor [KO:K06691 ]
7979 SEM1; SEM1 26S proteasome subunit [KO:K10881 ]
220988 HNRNPA3; heterogeneous nuclear ribonucleoprotein A3 [KO:K12741 ]
3178 HNRNPA1; heterogeneous nuclear ribonucleoprotein A1 [KO:K12741 ]
144983 HNRNPA1L2; heterogeneous nuclear ribonucleoprotein A1 like 2 [KO:K12741 ]
642659 HNRNPA1L3; heterogeneous nuclear ribonucleoprotein A1 like 3 [KO:K12741 ]
3181 HNRNPA2B1; heterogeneous nuclear ribonucleoprotein A2/B1 [KO:K13158 ]
283 ANG; angiogenin [KO:K16631 ] [EC:3.1.27.-]
4686 NCBP1; nuclear cap binding protein subunit 1 [KO:K12882 ]
6428 SRSF3; serine and arginine rich splicing factor 3 [KO:K12892 ]
6432 SRSF7; serine and arginine rich splicing factor 7 [KO:K12896 ]
29107 NXT1; nuclear transport factor 2 like export factor 1 [KO:K14285 ]
55916 NXT2; nuclear transport factor 2 like export factor 2 [KO:K14285 ]
7175 TPR; translocated promoter region, nuclear basket protein [KO:K09291 ]
4928 NUP98; nucleoporin 98 and 96 precursor [KO:K14297 ]
6396 SEC13; SEC13 homolog, nuclear pore and COPII coat complex component [KO:K14004 ]
9883 POM121; POM121 transmembrane nucleoporin [KO:K14316 ]
94026 POM121L2; POM121 transmembrane nucleoporin like 2 [KO:K14316 ]
5903 RANBP2; RAN binding protein 2 [KO:K12172 ] [EC:2.3.2.-]
400916 CHCHD10; coiled-coil-helix-coiled-coil-helix domain containing 10 [KO:K22759 ]
9217 VAPB; VAMP associated protein B and C [KO:K10707 ]
22926 ATF6; activating transcription factor 6 [KO:K09054 ]
1649 DDIT3; DNA damage inducible transcript 3 [KO:K04452 ]
2081 ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852 ] [EC:2.7.11.1 3.1.26.-]
9451 EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860 ] [EC:2.7.11.1 ]
1965 EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237 ]
468 ATF4; activating transcription factor 4 [KO:K04374 ]
3710 ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960 ]
10280 SIGMAR1; sigma non-opioid intracellular receptor 1 [KO:K20719 ]
7132 TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158 ]
7133 TNFRSF1B; TNF receptor superfamily member 1B [KO:K05141 ]
1616 DAXX; death domain associated protein [KO:K02308 ]
9973 CCS; copper chaperone for superoxide dismutase [KO:K04569 ]
7280 TUBB2A; tubulin beta 2A class IIa [KO:K07375 ]
9001 HAP1; huntingtin associated protein 1 [KO:K04647 ]
1767 DNAH5; dynein axonemal heavy chain 5 [KO:K10408 ]
1768 DNAH6; dynein axonemal heavy chain 6 [KO:K10408 ]
1770 DNAH9; dynein axonemal heavy chain 9 [KO:K10408 ]
8701 DNAH11; dynein axonemal heavy chain 11 [KO:K10408 ]
1769 DNAH8; dynein axonemal heavy chain 8 [KO:K10408 ]
8632 DNAH17; dynein axonemal heavy chain 17 [KO:K10408 ]
7802 DNALI1; dynein axonemal light intermediate chain 1 [KO:K10410 ]
27019 DNAI1; dynein axonemal intermediate chain 1 [KO:K10409 ]
64446 DNAI2; dynein axonemal intermediate chain 2 [KO:K11143 ]
6506 SLC1A2; solute carrier family 1 member 2 [KO:K05613 ]
2890 GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197 ]
2891 GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198 ]
2902 GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208 ]
2903 GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209 ]
2904 GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210 ]
2905 GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211 ]
2906 GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212 ]
Compound
C04549 1-Phosphatidyl-1D-myo-inositol 3-phosphate
Reference
Authors
Brown RH, Al-Chalabi A
Title
Amyotrophic Lateral Sclerosis.
Journal
Reference
Authors
Webster CP, Smith EF, Shaw PJ, De Vos KJ
Title
Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?
Journal
Reference
Authors
Valko K, Ciesla L
Title
Amyotrophic lateral sclerosis.
Journal
Reference
Authors
Mathis S, Goizet C, Soulages A, Vallat JM, Masson GL
Title
Genetics of amyotrophic lateral sclerosis: A review.
Journal
Reference
Authors
Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Shaw PJ, Swash M, Talbot K, Traynor BJ, Van den Berg LH, Veldink JH, Vucic S, Kiernan MC
Title
Controversies and priorities in amyotrophic lateral sclerosis.
Journal
Reference
Authors
Pasinelli P, Brown RH
Title
Molecular biology of amyotrophic lateral sclerosis: insights from genetics.
Journal
Reference
Authors
Goodall EF, Morrison KE
Title
Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment.
Journal
Reference
Authors
Smith EF, Shaw PJ, De Vos KJ
Title
The role of mitochondria in amyotrophic lateral sclerosis.
Journal
Reference
Authors
Kodavati M, Wang H, Hegde ML
Title
Altered Mitochondrial Dynamics in Motor Neuron Disease: An Emerging Perspective.
Journal
Reference
Authors
Hervias I, Beal MF, Manfredi G
Title
Mitochondrial dysfunction and amyotrophic lateral sclerosis.
Journal
Reference
Authors
Bacman SR, Bradley WG, Moraes CT
Title
Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?
Journal
Reference
Authors
Lin MT, Beal MF
Title
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.
Journal
Reference
Authors
Bendotti C, Bao Cutrona M, Cheroni C, Grignaschi G, Lo Coco D, Peviani M, Tortarolo M, Veglianese P, Zennaro E
Title
Inter- and intracellular signaling in amyotrophic lateral sclerosis: role of p38 mitogen-activated protein kinase.
Journal
Reference
Authors
Simpson EP, Yen AA, Appel SH
Title
Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis.
Journal
Reference
Authors
Bendotti C, Carri MT
Title
Lessons from models of SOD1-linked familial ALS.
Journal
Reference
Authors
Robertson J, Kriz J, Nguyen MD, Julien JP
Title
Pathways to motor neuron degeneration in transgenic mouse models.
Journal
Reference
Authors
Eve DJ, Dennis JS, Citron BA
Title
Transcription factor p53 in degenerating spinal cords.
Journal
Reference
Authors
Bahar E, Kim H, Yoon H
Title
ER Stress-Mediated Signaling: Action Potential and Ca(2+) as Key Players.
Journal
Reference
Authors
Bezprozvanny I
Title
Calcium signaling and neurodegenerative diseases.
Journal
Reference
Authors
von Lewinski F, Keller BU
Title
Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS.
Journal
Reference
Authors
Julien JP.
Title
Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded.
Journal
Reference
Authors
Hand CK, Rouleau GA
Title
Familial amyotrophic lateral sclerosis.
Journal
Reference
Authors
Barber SC, Mead RJ, Shaw PJ
Title
Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.
Journal
Reference
Authors
Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK
Title
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis.
Journal
Reference
Authors
Nguyen DKH, Thombre R, Wang J
Title
Autophagy as a common pathway in amyotrophic lateral sclerosis.
Journal
Reference
Authors
Lee JK, Shin JH, Lee JE, Choi EJ
Title
Role of autophagy in the pathogenesis of amyotrophic lateral sclerosis.
Journal
Reference
Authors
Oakes JA, Davies MC, Collins MO
Title
TBK1: a new player in ALS linking autophagy and neuroinflammation.
Journal
Reference
Authors
Ramesh N, Pandey UB
Title
Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand.
Journal
Reference
Authors
Kunita R, Otomo A, Mizumura H, Suzuki-Utsunomiya K, Hadano S, Ikeda JE
Title
The Rab5 activator ALS2/alsin acts as a novel Rac1 effector through Rac1-activated endocytosis.
Journal
Reference
Authors
Hadano S, Kunita R, Otomo A, Suzuki-Utsunomiya K, Ikeda JE
Title
Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.
Journal
Reference
Authors
Ruffoli R, Bartalucci A, Frati A, Fornai F
Title
Ultrastructural studies of ALS mitochondria connect altered function and permeability with defects of mitophagy and mitochondriogenesis.
Journal
Reference
Authors
Menzies FM, Fleming A, Rubinsztein DC
Title
Compromised autophagy and neurodegenerative diseases.
Journal
Reference
Authors
Casterton RL, Hunt RJ, Fanto M
Title
Pathomechanism Heterogeneity in the Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disease Spectrum: Providing Focus Through the Lens of Autophagy.
Journal
Reference
Authors
Lin G, Mao D, Bellen HJ
Title
Amyotrophic Lateral Sclerosis Pathogenesis Converges on Defects in Protein Homeostasis Associated with TDP-43 Mislocalization and Proteasome-Mediated Degradation Overload.
Journal
Reference
Authors
Hetz C, Mollereau B
Title
Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases.
Journal
Reference
Authors
Xiang C, Wang Y, Zhang H, Han F
Title
The role of endoplasmic reticulum stress in neurodegenerative disease.
Journal
Reference
Authors
Hughes D, Mallucci GR
Title
The unfolded protein response in neurodegenerative disorders - therapeutic modulation of the PERK pathway.
Journal
Reference
Authors
Doyle KM, Kennedy D, Gorman AM, Gupta S, Healy SJ, Samali A
Title
Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders.
Journal
Reference
Authors
Turner BJ, Atkin JD
Title
ER stress and UPR in familial amyotrophic lateral sclerosis.
Journal
Reference
Authors
Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, Fukutomi H, Noguchi T, Matsuzawa A, Takeda K, Ichijo H
Title
ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1.
Journal
Reference
Authors
Walker AK, Atkin JD
Title
Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis.
Journal
Reference
Authors
Renaud L, Picher-Martel V, Codron P, Julien JP
Title
Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.
Journal
Reference
Authors
Nguyen HP, Van Broeckhoven C, van der Zee J
Title
ALS Genes in the Genomic Era and their Implications for FTD.
Journal
Reference
Authors
Atkin G, Paulson H
Title
Ubiquitin pathways in neurodegenerative disease.
Journal
Reference
Authors
Kim JM, Billington E, Reyes A, Notarianni T, Sage J, Agbas E, Taylor M, Monast I, Stanford JA, Agbas A
Title
Impaired Cu-Zn Superoxide Dismutase (SOD1) and Calcineurin (Cn) Interaction in ALS: A Presumed Consequence for TDP-43 and Zinc Aggregation in Tg SOD1(G93A) Rodent Spinal Cord Tissue.
Journal
Reference
Authors
Benarroch EE
Title
Sigma-1 receptor and amyotrophic lateral sclerosis.
Journal
Reference
Authors
Millecamps S, Julien JP
Title
Axonal transport deficits and neurodegenerative diseases.
Journal
Related pathway
hsa04141 Protein processing in endoplasmic reticulum
hsa04810 Regulation of actin cytoskeleton
KO pathway
LinkDB
All DBs